Comprehensive Stroke Performance Measurement Implementation Guide

Size: px
Start display at page:

Download "Comprehensive Stroke Performance Measurement Implementation Guide"

Transcription

1 Comprehensive Stroke Performance Measurement Implementation Guide Release Notes Version: 2015Jan Release Notes Completed: November 14, 2014 Guidelines for Using Release Notes Release Notes 2015Jan provide modifications to the Comprehensive Stroke Performance Measurement Implementation Guide. The Release Notes are provided as a reference tool and are not intended to be used to program abstraction tools. Please refer to the complete and current technical specifications and abstraction information. The notes are organized to follow the order of the Table of Contents. The implementation date is , unless otherwise specified. The headings are described below: Impacts - used to identify the impacted measures and portion(s) of the Manual Section. (i.e., Alphabetical Data Dictionary, Measure Information Form (MIF) and Flowchart (Algorithm)). Description of Changes - used to identify the section within the document where the change occurs, e.g., Definition, Data Collection Question, Allowable Values, and Denominator Statement - Data Elements. Rationale - provided for the change being made. Data elements that cross multiple measures and contain the same changes will be consolidated. 1

2 Table of Contents SECTION 1 Data Dictionary... 3 Data Element Updates... 3 SECTION 2 Measurement Information... 6 SECTION 3 Missing and Invalid Data... 9 SECTION 4 Population and Sampling Specifications... 9 SECTION 5 Data Transmission APPENDICES

3 SECTION 1 Data Dictionary Data Element Updates First Pass Time Rationale: This change is to provide abstractor clarification for cases with procedure notes/reports with various different times documented. Anesthesia start time Groin puncture time Procedure start time Highest NIHSS Score Documented Within 36 Hours Following IA t-pa or MER Initiation Rationale: This change is to provide abstractor clarification about NIHSS score documentation. Modified NIHSS scores Estimated NIHSS scores Scoring methodologies other than NIHSS Highest NIHSS Score Documented Within 36 Hours Following IV Thrombolytic Initiation Rationale: This change is to provide abstractor clarification about NIHSS score documentation. Modified NIHSS scores Estimated NIHSS scores Scoring methodologies other than NIHSS 3

4 ICD-9-CM Other Procedure Times Rationale: Correct typo. Format Occurs: 24 IA Route of t-pa Administration Rationale: This change is to provide abstractor clarification for cases with intra-arterial administration of thrombolytic agents. IA administration of thrombolytic agents not listed as inclusions. IA Thrombolytic Initiation Rationale: This change is to provide abstractor clarification for cases with IA Route of t-pa Administration YES. Notes for Abstraction: If the data element IA Route of t-pa Administration is YES, select YES for this data element. IA administration of thrombolytic agents not listed as inclusions. Initial Blood Pressure at Hospital Arrival Rationale: Correct typo. Format Length: 7 Initial NIHSS Score at Hospital Arrival 4

5 Rationale: This change is to provide abstractor clarification about NIHSS score documentation. Modified NIHSS scores Estimated NIHSS scores Scoring methodologies other than NIHSS Modified Rankin Score Rationale: This change is to provide abstractor clarification for cases when the caregiver is a nursing home or extended or immediate care facility. Notes For Abstraction If documentation reflects that the mrs could not be obtained because the patient is a resident of a nursing home or extended/immediate care facility, and the facility refuses to provide patient information due to HIPPA regulations or other reasons, select allowable value 7. NIHSS Score Documented Closest to IA t-pa or MER Initiation Rationale: This change is to provide abstractor clarification about NIHSS score documentation. Modified NIHSS scores Estimated NIHSS scores Scoring methodologies other than NIHSS NIHSS Score Documented Closest to IV Thrombolytic Initiation Rationale: This change is to provide abstractor clarification about NIHSS score documentation. Modified NIHSS scores Estimated NIHSS scores 5

6 Scoring methodologies other than NIHSS SECTION 2 Measurement Information Measure(s) CSTK-06 Rationale: Correct simple error. Selected References 4. Connolly ES, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dio J, Higashida RT, Hoh BL, Kirkness CJ, Naidech AM, Ogilvy CS, Patel AB, Thompson BG, Vespa P. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guidelines for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012;43:1-27. Measure(s) CSTK-01, CSTK-03 Rationale: Correct simple error. Data Elements (Numerator) ICD-9-CM Other Procedure Dates ICD-9-CM Other Procedure Times ICD-9-CM Principal Procedure Date ICD-9-CM Principal Procedure Time Data Elements (Denominator) Remove: ICD-9-CM Other Procedure Dates ICD-9-CM Other Procedure Times ICD-9-CM Principal Procedure Date ICD-9-CM Principal Procedure Time Algorithms Measure(s) CSTK-01, CSTK-03 6

7 Rationale: This change adds a note box to define the earliest procedure date and the earliest procedure time in order to handle the cases with multiple procedure codes. CSTK-01, CSTK-03 Note box: ICD-9-CM Principal or Other Procedure Date and Time CSTK-03 Measurement Date and Measurement Time process box under Initial Hunt and Hess Scale Time decision point If Initial Hunt and Hess Scale Time is Non-UTD value, then The Measurement Date = Initial Hunt and Hess Scale Date The Measurement Time = Initial Hunt and Hess Scale Time Measurement Date and Measurement Time process box under Initial ICH Score Time decision point If Initial ICH Score Time is Non-UTD value, then The Measurement Date = Initial ICH Score Date The Measurement Time = Initial ICH Score Time CSTK-01, CSTK-02, CSTK-03, CSTK-06 Rationale: Discharge Date is a required data element and does not need a decision box within a measure algorithm. Remove: Discharge Date decision box and all associate logic CSTK-05 Rationale: Correction of Measure Category Assignments for outputs throughout the measure because it is an inverse measure. Change: All measure category assignments of D are changed to E and all E s are changed to D s. CSTK-07 Rationale: This change corrects algorithm dead end when IA t-pa and MER therapies are performed. 1. Initial MER flag and IA flag to N under ICD-9-CM Principal or Other Procedure Codes decision point 2. Check ICD-9-CM Principal or Other Procedure Codes 7

8 If None of ICD-9-CM Principal or Other Procedure Codes is on Table 8.1a, case flows to Step 3 and re-check ICD-9-CM Principal or Other Procedure Codes If Any of ICD-9-CM Principal or Other Procedure Codes is on Table 8.1a, case flows to Step 4 and check IA Route of t-pa Administration 3. Re-check ICD-9-CM Principal or Other Procedure Codes If Any of ICD-9-CM Principal or Other Procedure Codes is on Table 8.1b, set MER flag to Y, case flows MER branch 4. Check IA Route of t-pa Administration If IA Route of t-pa Administration is missing, case flows to Measure Category Assignment of X If IA Route of t-pa Administration is N, case flows to Step 3 and re-check ICD-9-CM Principal or Other Procedure Codes If IA Route of t-pa Administration is Y, case flows to Step 5 and re-check ICD-9-CM Principal or Other Procedure Codes 5. Re-check ICD-9-CM Principal or Other Procedure Codes If Any of ICD-9-CM Principal or Other Procedure Codes is on Table 8.1b, set MER flag and IA flag to Y, case flow down IAMER branch If None of ICD-9-CM Principal or Other Procedure Codes is on Table 8.1b, set IA flag to Y, case flow to IA branch CSTK-08 Rationale: This change corrects algorithm dead end when IA t-pa and MER therapies are performed. Re-check ICD-9-CM Principal or Other Procedure Codes decision point logic If None of ICD-9-CM Principal or Other Procedure Codes is on Table 8.1b, case flows to check IA Route of t-pa Administration decision point If Any of ICD-9-CM Principal or Other Procedure Codes is on Table 8.1b, case flows down CSTK-01, CSTK-02, CSTK-03, CSTK-05, CSTK-07, CSTK-08 Rationale: This change adjusts the method of handling cases without procedure code in the required tables. ICD-9-CM Principal or Other Procedure Codes decision point logic 8

9 If All missing or None of ICD-9-CM Principal or Other Procedure Codes is on Table 8.1a or 8.1b, case flows to Measure Category Assignment of B If Any of ICD-9-CM Principal or Other Procedure Codes is on Table 8.1a or 8.1b, case flows down CSTK-03 If All missing or None of ICD-9-CM Principal or Other Procedure Codes is on Table 8.2d or 8.2e, case flows to Measure Category Assignment of B If Any of ICD-9-CM Principal or Other Procedure Codes is on Table 8.2d or 8.2e, case flows down CSTK-07 Rationale: This change corrects a simple error. First Pass Date and IA Thrombolytic Initiation Date decision point logic If First Pass Date or IA Thrombolytic Initiation Date is UTD, case flows to Measure Category Assignment of Y If First Pass Date or IA Thrombolytic Initiation Date is Non-UTD value, case flows down First Pass Time and IA Thrombolytic Initiation Time decision point logic If First Pass Time or IA Thrombolytic Initiation Time is UTD, case flows to Measure Category Assignment of Y If First Pass Time or IA Thrombolytic Initiation Time is Non-UTD value, case flows down SECTION 3 Missing and Invalid Data Hospital Clinical Data (HCD) submission for CSTK data, Edits, Algorithms Rationale: The CSTK data will be submitted by vendors starting July 2015 for discharge data 1/1/2015 and are processed using The Joint Commission HCD application. This new section of Missing and Invalid Data is added to the guide to define the terms and the protocol of reporting and processing of missing or invalid data. SECTION 4 Population and Sampling Specifications 9

10 Population and Sampling (PaS) CSTK data submission Rationale: The CSTK data will be submitted by vendors starting July 2015 for discharge data 1/1/2015 and are processed using The Joint Commission HCD application. This new section of Population and Sampling Specifications is added to the guide to define the terms and the methodology of sampling and provide general examples of sampling for different topics/measure sets. SECTION 5 Data Transmission Population and Sampling (PaS) data submission, Hospital Clinical Data (HCD) data submission Rationale: The CSTK data will be submitted by vendors starting July 2015 for discharge data 1/1/2015 and are processed using The Joint Commission's Hospital Clinical Data (HCD) and Population and Sampling (PaS) applications. This new section of Data Transmission is added to the guide related to the transmission and processing of CSTK data for the Joint Commission s Data Warehouse. Guidance is added to provide details on Transmission Data Elements and expected file formats to submit data to The Joint Commission, using HCD and PaS applications, and explains the processing steps taken by each application. This section also provides details and examples on submission of data for CSTK discharge measures (discharge file) and CSTK follows-up measure (event file). APPENDICES Appendix A ICD-9-CM Code Tables No updates in this section. 10

Measure Harmonization. Guidance for Measure Harmonization A CONSENSUS REPORT

Measure Harmonization. Guidance for Measure Harmonization A CONSENSUS REPORT Measure Harmonization Guidance for Measure Harmonization A CONSENSUS REPORT National Quality Forum The National Quality Forum (NQF) operates under a three-part mission to improve the quality of American

More information

MEANINGFUL USE CRITERIA PHYSICIANS

MEANINGFUL USE CRITERIA PHYSICIANS MEANINGFUL USE CRITERIA PHYSICIANS The first list is of the 25 Stage 1 Meaningful Use criteria for eligible providers (EP) and comes from the proposed rule: "Medicare and Medicaid Programs; Electronic

More information

The Value of Agile Self-Service Analytics. Mike Zuschin Director, Decision Support & Business Intelligence March 3 rd 2016

The Value of Agile Self-Service Analytics. Mike Zuschin Director, Decision Support & Business Intelligence March 3 rd 2016 The Value of Agile Self-Service Analytics Mike Zuschin Director, Decision Support & Business Intelligence March 3 rd 2016 Agenda Cleveland Clinic & Early Analytics Success: The Phantom Menace Meeting Increased

More information

Integrated Healthcare Association Value-Based Pay-for-Performance Program. Audit Review Guidelines Measurement Year Released November 2017

Integrated Healthcare Association Value-Based Pay-for-Performance Program. Audit Review Guidelines Measurement Year Released November 2017 Integrated Healthcare Association Value-Based Pay-for-Performance Program Audit Review Guidelines Measurement Year 2017 Released November 2017 Content reproduced from HEDIS 2018, Volume 5: HEDIS Compliance

More information

General Guidelines. In this sense, contribution of distinct individuals to the outcome of scientific analysis needs to be properly acknowledged.

General Guidelines. In this sense, contribution of distinct individuals to the outcome of scientific analysis needs to be properly acknowledged. PUBLICATIONS GUIDELINES FOR RETROSPECTIVE STUDIES, NON-INTERVENTIONAL PROSPECTIVE TRIALS, AND PROSPECTIVE CLINICAL TRIALS OF THE EUROPEAN GROUP FOR BLOOD AND BONE MARROW TRANSPLANTATION. VERSION JUNE/2012

More information

Composite Performance Measure Evaluation Guidance. April 8, 2013

Composite Performance Measure Evaluation Guidance. April 8, 2013 Composite Performance Measure Evaluation Guidance April 8, 2013 Contents Introduction... 1 Purpose... 1 Background... 2 Prior Guidance on Evaluating Composite Measures... 2 NQF Experience with Composite

More information

Quality Risk Management

Quality Risk Management Implementation of ICH Q8, Q9, Q10 Quality Risk Management International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Introduction Structure of

More information

Current Trends at FDA: Implications for Data Requirements

Current Trends at FDA: Implications for Data Requirements Introduction The environment surrounding medical device regulation in the United States has always been rigorous, but recent events including well-publicized quality issues associated with implantable

More information

Over a Hundred Reporting Clients throughout the country. 95%+ Client Retention

Over a Hundred Reporting Clients throughout the country. 95%+ Client Retention The Leader in Web-based Reporting for Managed Care Organizations Diverse base of Managed Care clients (IPAs, PHOs, HMOs & MSOs) Providing Managed Care Analytics and Business Intelligence for over 10 years

More information

QUALITY IMPROVEMENT FORM

QUALITY IMPROVEMENT FORM QUALITY IMPROVEMENT FORM NCQA Quality Improvement Activity Form (an electronic version is available on NCQA's Web site) Activity Name: Section I: Activity Selection and Methodology A. Rationale. Use objective

More information

Managing the Transition to Electronic Clinical Quality Measures

Managing the Transition to Electronic Clinical Quality Measures WHITE PAPER Managing the Transition to Electronic Clinical Quality Measures By Randy L. Thomas, FHIMSS, Managing Director for Value Realization & Performance An Encore Point of View Analytics, Liz Richard,

More information

Considerations for Choosing MIPS Quality Measures. July 2017

Considerations for Choosing MIPS Quality Measures. July 2017 Considerations for Choosing MIPS Quality Measures July 2017 Overview of Contents First know yourself Finding measures Understanding scoring Special Considerations about registries Special Considerations

More information

RECRUITMENT TRACKING AND SCHEDULING FORM

RECRUITMENT TRACKING AND SCHEDULING FORM OMB#: 0925-0281 Exp. 3/31/2014 RECRUITMENT TRACKING AND SCHEDULING FORM ID NUMBER: FORM CODE: R T S DATE: 09/01/2011 Version 2.0 ADMINISTRATIVE INFORMATION 0a. Completion Date: / / 0b. Staff ID: Month

More information

Spartanburg Regional Healthcare System

Spartanburg Regional Healthcare System Spartanburg Regional Healthcare System Leveraging the WiFi Network for RTLS RFID @ SRHS March 28, 2007 1 Spartanburg Regional Healthcare System Integrated Delivery System 2 hospitals, 588 licensed beds

More information

United Healthcare (UHC) Review Notification, Subscriber and Dependent v1.2

United Healthcare (UHC) Review Notification, Subscriber and Dependent v1.2 United Healthcare (UHC) Review Notification, Subscriber and Dependent v1.2 5.19.2017 This publication is the proprietary property of Emdeon and is furnished solely for use pursuant to a license agreement

More information

Implementing Benefit-Risk Management More Effectively

Implementing Benefit-Risk Management More Effectively Implementing Benefit-Risk Management More Effectively Steve Mayall, Principal Consultant June 2017 Pope Woodhead & Associates Ltd. The Old Grammar School, 1 Ramsey Road, St. Ives, Cambridgeshire, PE27

More information

TC 3 Health an Emdeon Company, ICD-10 Frequently Asked Questions. Published Q2 2014

TC 3 Health an Emdeon Company, ICD-10 Frequently Asked Questions. Published Q2 2014 TC 3 Health an Emdeon Company, ICD-10 Frequently Asked Questions Published Q2 2014 Preface This information is provided by TC 3 Health, an Emdeon Company for education and awareness use only. Even though

More information

Technology Trends and Impacts on CDI Programs. Tim Minnich, Solution Sales Executive, Mobile:

Technology Trends and Impacts on CDI Programs. Tim Minnich, Solution Sales Executive, Mobile: Technology Trends and Impacts on CDI Programs Tim Minnich, Solution Sales Executive, Tim.minnich@optum.com Mobile: 610-587-7366 Computer Assisted Coding & NLP The use of computer software that automatically

More information

EMPLOYMENT ACTION PLAN EXAMPLE

EMPLOYMENT ACTION PLAN EXAMPLE 24 April, 2018 EMPLOYMENT ACTION PLAN EXAMPLE Document Filetype: PDF 495.08 KB 0 EMPLOYMENT ACTION PLAN EXAMPLE The employment action plan will be based on four main guidelines adopted by the European

More information

FDA Medical Device HFE Guidance

FDA Medical Device HFE Guidance W H I T E P A P E R www.makrocare.com U S FDA has established a new Draft Guidance; Applying Human Factors and Usability Engineering to Medical Devices to Optimize Safety and Effectiveness in Design. Manufacturers

More information

Preventable Serious Adverse Events Present on Admission Diagnoses and POA Indicators Update

Preventable Serious Adverse Events Present on Admission Diagnoses and POA Indicators Update November 5, 2008 Preventable Serious Adverse Events Present on Admission Diagnoses and POA Indicators Update Dear Keystone Mercy Acute Care Hospital Provider, On July 30, 2008, Keystone Mercy sent a letter

More information

Improve Patient Satisfaction Through Employee Rounding. Tracking & Improving Employee Satisfaction Scores

Improve Patient Satisfaction Through Employee Rounding. Tracking & Improving Employee Satisfaction Scores Improve Patient Satisfaction Through Employee Rounding Tracking & Improving Employee Satisfaction Scores Table of Contents Overview Rounding and Communication Rounding and Employee Engagement Rounding

More information

Author Signature: Date: 10 October 2017 The author is signing to confirm the technical content of this document

Author Signature: Date: 10 October 2017 The author is signing to confirm the technical content of this document SOP Title: Investigator s Brochure Content, Design, Amendments, Filing & Distribution Author: Clinical Research and Development Office (CRDO) Author Signature: Date: 10 October 2017 The author is signing

More information

Recommendation on elements required to support the medical plausibility and the assumption of significant benefit for an orphan designation

Recommendation on elements required to support the medical plausibility and the assumption of significant benefit for an orphan designation 2 March 2010 EMA/COMP/15893/2009 Final Committee for Orphan Medicinal Products (COMP) Recommendation on elements required to support the medical plausibility and the assumption of significant benefit for

More information

DATA QUALITY POLICY. Ref No:

DATA QUALITY POLICY. Ref No: Ref No: DATA QUALITY POLICY Version: 4e Ratified by: Policy Ratification Group Date ratified: 15 December 2010 Name of author: Head of Information & Performance Name of responsible committee: Quality Committee

More information

AMCH PPS. Clinical & Quality Affairs Committee

AMCH PPS. Clinical & Quality Affairs Committee AMCH PPS Clinical & Quality Affairs Committee Kallanna Manjunath MD, FAAP, CPE George Clifford, PhD Brendon Smith, PhD Susan Kopp, MBA, BSN, RN February 24, 2016 AMCH PPS: Clinical & Quality Affairs (CQA)

More information

Application of ICH Q12 Tools and Enablers

Application of ICH Q12 Tools and Enablers Joint BWP/QWP/GMDP IWG Industry European Workshop on Lifecycle Management Application of ICH Q12 Tools and Enablers Lifecycle Strategy 2015-10-26 1 Outline Introduction: Lifecycle Strategy - a new concept

More information

Study Files and Filing

Study Files and Filing Study Files and Filing The current version of all Hillingdon Hospital R&D Guidance Documents and Standard Operating Procedures are available from the R&D Intranet and Internet sites: www.ths.nhs.uk/departments/research/research.htm

More information

Data Collection and Aggregation: Making It Work for Your P4P Program

Data Collection and Aggregation: Making It Work for Your P4P Program Data Collection and Aggregation: Making It Work for Your P4P Program Dolores Yanagihara, MPH Integrated Healthcare Association February 27, 2008 National P4P Summit Overview The Data Problem Data Sources

More information

CANCER CENTER SCIENTIFIC REVIEW COMMITTEE

CANCER CENTER SCIENTIFIC REVIEW COMMITTEE CANCER CENTER SCIENTIFIC REVIEW COMMITTEE The Clinical Scientific Review Committee (SRC) at The Medical College of Wisconsin Cancer Center plays a vital role in protocol review and monitoring to ensure

More information

April 15, 2015 VIA ELECTRONIC MAIL

April 15, 2015 VIA ELECTRONIC MAIL April 15, 2015 VIA ELECTRONIC MAIL Patricia Brooks, RHIA Senior Technical Advisor Centers for Medicare and Medicaid Services Hospital and Ambulatory Policy Group Mail Stop C4-08-06 7500 Security Boulevard

More information

Clinical Integration Tools Release Notes The Leading Telehealth Network & Service Provider

Clinical Integration Tools Release Notes The Leading Telehealth Network & Service Provider InTouch Health and the Clinical Integration Tools product team are pleased to announce the Clinical Integration Tools 3.4 release. The 3.4 release is a result of our commitment to partner with our customers

More information

Re: Docket No. FDA-2008-D-0386: International Conference on Harmonisation; Draft Guidance on E2F Development Safety Update Report; Availability.

Re: Docket No. FDA-2008-D-0386: International Conference on Harmonisation; Draft Guidance on E2F Development Safety Update Report; Availability. 1201 Maryland Avenue SW, Suite 900, Washington, DC 20024 202-962-9200, www.bio.org November 03, 2008 Dockets Management Branch (HFA-305) Food and Drug Administration 5600 Fishers Lane, Rm. 1061 Rockville,

More information

WL-Guidance document Relating to the fast-track authorisation procedure

WL-Guidance document Relating to the fast-track authorisation procedure List of contents 1 Definitions, terms, abbreviations... 2 1.1 Abbrevations... 2 2 Introduction and Purpose... 2 3 Scope... 3 4 Legal basis... 3 5 Other applicable documents... 3 6 Part 1: Application for

More information

DATA QUALITY POLICY Review Date: CONTENT

DATA QUALITY POLICY Review Date: CONTENT Title: Date Approved: Approved by: DATA QUALITY POLICY Review Date: Policy Ref: Issue: Jan 2010 Sherwood Forest Hospitals Oct 2011 Information Governance Group Division/Department: Policy Category: ISP_03

More information

Standard Operating Procedures Guidelines for Good Clinical Practice

Standard Operating Procedures Guidelines for Good Clinical Practice SOP # CRSC-105 Effective Date 10-22-2013 Version # 1 Version Date 7-30-2013 Standard Operating Procedures Guidelines for Good Clinical Practice Purpose: This SOP outlines the steps required to follow FDA

More information

Overview of Amgen s CQP Commissioning and Qualification Program Steve Wisniewski Principal Compliance Consultant, CAI Past Chairman ISPE C&Q COP

Overview of Amgen s CQP Commissioning and Qualification Program Steve Wisniewski Principal Compliance Consultant, CAI Past Chairman ISPE C&Q COP May 1-3, 2012 Javits Center New York, NY Introduction to ISPE GUIDE: SCIENCE AND RISK-BASED APPROACH FOR THE DELIVERY OF FACILITIES, SYSTEMS, AND EQUIPMENT & Overview of Amgen s CQP Commissioning and Qualification

More information

Administration Bldg. #9 Purchasing Department- Ground Floor Suite 12 One College Drive, Toms River, New Jersey 08753

Administration Bldg. #9 Purchasing Department- Ground Floor Suite 12 One College Drive, Toms River, New Jersey 08753 ADDENDUM 1 BID- Background Check Screening Services Reference 13/14 B46 New due date: Location: December 20, 2013 10:00 a.m. Ocean County College Administration Bldg. #9 Purchasing Department- Ground Floor

More information

Coding Essentials for Infusion and Injection Therapy Services 2018

Coding Essentials for Infusion and Injection Therapy Services 2018 Coding Essentials for Infusion and Injection Therapy Services 2018 A guide for outpatient injections, non-chemotherapy and chemotherapy administration services Prepared and Published By: MedLearn Publishing

More information

St. Lucie Public Schools

St. Lucie Public Schools April 26, 2016 TO: FROM: RE: All Prospective Proposers Kim Albritton Coordinator of Business Services RFP 16-18 Speech-Language Therapy & Audiology Services ADDENDUM 1 TO RFP 16-18 SPEECH-LANGUAGE THERAPY

More information

1.4 Applicable Regulatory Requirement(s) Any law(s) and regulation(s) addressing the conduct of clinical trials of investigational products.

1.4 Applicable Regulatory Requirement(s) Any law(s) and regulation(s) addressing the conduct of clinical trials of investigational products. 1.1 Adverse Drug Reaction (ADR) In the pre-approval clinical experience with a new medicinal product or its new usages, particularly as the therapeutic dose(s) may not be established: all noxious and unintended

More information

Starting Material Selection for Type II Drug Master Files

Starting Material Selection for Type II Drug Master Files Starting Material Selection for Type II Drug Master Files Ronald S. Michalak Quality Assessment Lead (Acting), Division of Lifecycle API Office of New Drug Products, OPQ/CDER/ FDA CDER Reorganization Office

More information

The role of SNOMED CT in healthcare systems across the world Jan-Eric Slot MB MSc MBA CEO IHTSDO

The role of SNOMED CT in healthcare systems across the world Jan-Eric Slot MB MSc MBA CEO IHTSDO The role of SNOMED CT in healthcare systems across the world Jan-Eric Slot MB MSc MBA CEO IHTSDO International Health Terminology Standards Development Organisation www.ihtsdo.org 1 Outline What is the

More information

NOTICE OF SUBSTANTIAL AMENDMENT

NOTICE OF SUBSTANTIAL AMENDMENT NOTICE OF SUBSTANTIAL AMENDMENT For use in the case of all research other than clinical trials of investigational medicinal products (CTIMPs). For substantial amendments to CTIMPs, please use the EU-approved

More information

Profibrinolytic diabody targeting PAI-1 and TAFI for treatment of acute thrombotic disorders

Profibrinolytic diabody targeting PAI-1 and TAFI for treatment of acute thrombotic disorders ProFiDIΛ Profibrinolytic diabody targeting PAI-1 and TAFI for treatment of acute thrombotic disorders THROMBOLYSIS WITH IMPROVED SAFETY A valorisation project of Unmet Medical Need = Safe Thrombolysis

More information

MISSION - Set (align) the arm bone, then apply the blue cast. The cast needs to be all the way down, and it needs to completely cover the break.

MISSION - Set (align) the arm bone, then apply the blue cast. The cast needs to be all the way down, and it needs to completely cover the break. 2010 FLL CHALLENGE robot game Missions Biomedical engineering is the use of various engineering disciplines to help doctors and hospitals help patients. The fields of chemical, mechanical, electrical,

More information

Perioperative management of patients on warfarin requiring elective surgery Dr K Boyd, Mrs S Doyle

Perioperative management of patients on warfarin requiring elective surgery Dr K Boyd, Mrs S Doyle CLINICAL GUIDELINES ID TAG Title: Author: Speciality / Division: Directorate: Perioperative management of patients on warfarin requiring elective surgery Dr K Boyd, Mrs S Doyle Haematology Acute Date Uploaded:

More information

Volunteering for Clinical Trials

Volunteering for Clinical Trials Volunteering for Clinical Trials Volunteering for Clinical Trials When considering volunteering for a clinical trial, it is important to make an informed decision. Below are answers to frequently asked

More information

Quality ID #262: Image Confirmation of Successful Excision of Image-Localized Breast Lesion National Quality Strategy Domain: Patient Safety

Quality ID #262: Image Confirmation of Successful Excision of Image-Localized Breast Lesion National Quality Strategy Domain: Patient Safety Quality ID #262: Image Confirmation of Successful Excision of Image-Localized Breast Lesion National Quality Strategy Domain: Patient Safety 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE

More information

BUPA UK CLINICAL GOVERNANCE ASSURANCE POLICY. bupa.com

BUPA UK CLINICAL GOVERNANCE ASSURANCE POLICY. bupa.com BUPA UK CLINICAL GOVERNANCE ASSURANCE POLICY bupa.com Date November 2016 Document Details Table of Amendments Document New Issue New Issue Description of Change Authorisation Number Number Date Version

More information

Sponsorship of Clinical Research Studies

Sponsorship of Clinical Research Studies Sponsorship of Clinical Research Studies Category: Summary: Equality Impact Assessment undertaken: Policy The UK Policy Framework for Health and Social Care 2017 (UKPF) and The Medicines for Human Use

More information

Welcome to B.C. PharmaCare's Public Input Questionnaire for drugs being reviewed under the B.C. Drug Review Process.

Welcome to B.C. PharmaCare's Public Input Questionnaire for drugs being reviewed under the B.C. Drug Review Process. Welcome to B.C. PharmaCare's Public Input Questionnaire for drugs being reviewed under the B.C. Drug Review Process. This caregiver questionnaire is for [enter name of SEB under review] which is being

More information

9. Chapter 9: Data Management Procedures

9. Chapter 9: Data Management Procedures 9. Chapter 9: Data Management Procedures 9.1 General Instructions for Completing Forms All ENRICHD study data should be recorded on official ENRICHD data collection forms provided by the coordinating center.

More information

SOP: RECRUITMENT AND ADVERTISING MATERIALS IN USF HEALTH CLINIC WAITING AREAS

SOP: RECRUITMENT AND ADVERTISING MATERIALS IN USF HEALTH CLINIC WAITING AREAS SOP: RECRUITMENT AND ADVERTISING MATERIALS IN USF HEALTH CLINIC WAITING AREAS Catherine Jahrsdorfer, R.N., B.S.N. Director of Clinical Services Office of Clinical Research January 2 & 3, 2012 Learning

More information

ClinicalTrials.gov Registration Guide

ClinicalTrials.gov Registration Guide ClinicalTrials.gov Registration Guide The Food and Drug Administration Amendments Act (FDAAA), National Institutes of Health (NIH) and International Committee of Medical Journal Editors (ICMJE) require

More information

Training Bulletin. Emergency Health Services Branch Ministry of Health and Long-Term Care. October 24, Issue Number version 2.

Training Bulletin. Emergency Health Services Branch Ministry of Health and Long-Term Care. October 24, Issue Number version 2. Training Bulletin Ebola Virus Disease October 24, 2014 Issue Number 114 - version 2.1 Emergency Health Services Branch Ministry of Health and Long-Term Care Training Bulletin, Issue Number 114 version

More information

Regulatory Starting Materials An FDA Perspective

Regulatory Starting Materials An FDA Perspective Regulatory Starting Materials An FDA Perspective Kasturi Srinivasachar Branch Chief (Acting), New Drug API Division Office of New Drug Products, OPQ/CDER/ FDA 1 CDER Reorganization Office of Pharmaceutical

More information

ICD-10 Trends Real Talk OBJECTIVES: Disclaimers FHIMA 6/8/2016. KYoumans 1. Karen Youmans, MPA, RHIA, CCS President, YES HIM Consulting, Inc.

ICD-10 Trends Real Talk OBJECTIVES: Disclaimers FHIMA 6/8/2016. KYoumans 1. Karen Youmans, MPA, RHIA, CCS President, YES HIM Consulting, Inc. ICD-10 Trends Real Talk Karen Youmans, MPA, RHIA, CCS President, YES HIM Consulting, Inc. OBJECTIVES: At the end of this session, the attendee will be able to: Discuss coder productivity under ICD-10-CM/PCS

More information

Implementation Life-cycle SOP

Implementation Life-cycle SOP 1.0 Commercial in Confidence 11-Aug-2006 1 of 12 Implementation Life-cycle SOP Document No: H4_SOP_0100 Prepared by: David Brown Date: 11-Aug-2006 Version: 1.0 1.0 Commercial in Confidence 11-Aug-2006

More information

What is the purpose of this website?

What is the purpose of this website? What is the purpose of this website? This website aims to explain: How it is possible for different methods to give different results for the same test on the same patient sample Why it is important to

More information

Preparing For & Managing a RADV Audit

Preparing For & Managing a RADV Audit Preparing For & Managing a RADV Audit Session 607 Dennis P.H. Mihale, MD, MBA Scott Weiner, CMA, CFM, MBA Agenda Assessing Your Risk CMS RADV Process Health Plan Process Preparation Execution Mock Audit

More information

PSMF in Practice Your Questions Answered! GPvP Symposium, 14 March 2014 Jonathan Rowell, Senior GPvP Inspector

PSMF in Practice Your Questions Answered! GPvP Symposium, 14 March 2014 Jonathan Rowell, Senior GPvP Inspector PSMF in Practice Your Questions Answered! GPvP Symposium, 14 March 2014 Jonathan Rowell, Senior GPvP Inspector Content Answer industry questions related to the PSMF MHRA inspector s preparation: How we

More information

IV tpa: 1996 to Present

IV tpa: 1996 to Present IV tpa: 1996 to Present Where We ve Come From & What We ve Learned 1 Many of the things that seem impossible now will become realities of tomorrow. 2 Streptococcus Discovered back in the 1930s Activates

More information

How to Apply for Ethics (Non-CTIMPs) including Sponsorship

How to Apply for Ethics (Non-CTIMPs) including Sponsorship How to Apply for Ethics (Non-CTIMPs) including Sponsorship Joint Research & Enterprise Office (JREO) St George s University of London Lucy H H Parker Clinical Research Governance Manager Joint Research

More information

EDI Solutions Your guide to getting started -- and ensuring smooth transactions anthem.com/edi

EDI Solutions Your guide to getting started -- and ensuring smooth transactions anthem.com/edi EDI Solutions Your guide to getting started -- and ensuring smooth transactions anthem.com/edi 00175LNPEN (04/12) This brochure is a helpful EDI reference for both new and experienced electronic submitters.

More information

Introduction to Clinical Research

Introduction to Clinical Research Introduction to Clinical Research What is Clinical Research? Clinical research is medical research that involves people like you. People volunteer to participate in carefully conducted investigations that

More information

Computer System Validation & Backup

Computer System Validation & Backup REFERENCE: VERSION NUMBER: 1.1 EFFECTIVE DATE: 28-03-18 REVIEW DATE: 28-03-20 AUTHOR: Clinical Trials Manager, Clinical Trials Officer REVIEWED BY: R&I Senior Team APPROVED BY: Deputy Director of Research

More information

RFID Vendor Collaboration and Meeting the Needs of Your Clients

RFID Vendor Collaboration and Meeting the Needs of Your Clients RFID Vendor Collaboration and Meeting the Needs of Your Clients By Raymond Lowe Email: Raymond.lowe@providence.org Providence Health and Services IS Director Saint Joseph Medical Center Ca Regional Director

More information

EMS SERVICE ZONE PLAN APPLICATION

EMS SERVICE ZONE PLAN APPLICATION EMS SERVICE ZONE PLAN APPLICATION SERVICE ZONE NAME REGIONAL OFFICAL USE ONLY Plan Date Received Plan Reviewed Plan Returned with Recommendations Recommended To OEMS OEMS OFFICAL USE ONLY Plan Date Received

More information

Also contact Nancy if you want any changes or updates made to your listing at any time.

Also contact Nancy if you want any changes or updates made to your listing at any time. Arizona Telemedicine Program National Telemedicine & Telehealth Service Provider Directory Step-by-step Instructions for Completing Service Provider Questionnaire Contact Information: Below are instructions

More information

INFORMATION GOVERNANCE STRATEGY. Documentation control

INFORMATION GOVERNANCE STRATEGY. Documentation control INFORMATION GOVERNANCE STRATEGY Documentation control Reference Date Approved Approving Body Version Supersedes Consultation Undertaken Target Audience Supporting procedures GG/INF/01 TRUST BOARD Information

More information

A Guide to Clinical Coding Audit Best Practice Version 8.0

A Guide to Clinical Coding Audit Best Practice Version 8.0 A Guide to Clinical Coding Audit Best Practice Version 8.0 Copyright 2017 Health and Social Care Information Centre Page 1 of 17 The Health and Social Care Information Centre is a non-departmental body

More information

PROPRIETARY NAME REVIEW(S)

PROPRIETARY NAME REVIEW(S) CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 125553Orig1s000 PROPRIETARY NAME REVIEW(S) PROPRIETARY NAME REVIEW Division of Medication Error Prevention and Analysis (DMEPA) Office of Medication

More information

Explanatory Note to GVP Module VII

Explanatory Note to GVP Module VII 31 October 2017 EMA/670256/2017 Human Medicines Evaluation Division Explanatory Note to GVP Module VII Since the start of the Periodic Safety Update Report (PSUR) single assessment (PSUSA), the procedure

More information

External Audit: Annual Audit Letter

External Audit: Annual Audit Letter INFRASTRUCTURE, GOVERNMENT AND HEALTHCARE External Audit: Annual Audit Letter 2005-06 Southport and Ormskirk Hospital NHS Trust September 2006 AUDIT Content The contacts at KPMG in connection with this

More information

Massive Haemorrhage J Davies B Ferguson

Massive Haemorrhage J Davies B Ferguson Massive Haemorrhage J Davies B Ferguson What is Massive Haemorrhage (MH)? Difficult to apply rules as to how much blood loss defines a major haemorrhage. Easier to define how the patient s condition is

More information

POLST Paradigm Form Registries

POLST Paradigm Form Registries POLST Paradigm Form Registries State Topic Idaho New York Oregon Utah Washington West Virginia Active for POLST Paradigm Forms Yes Yes Yes Yes No Yes Documents Retained in Form repository: POST forms,

More information

Charge Capture: What You Don t Know IS Killing You!

Charge Capture: What You Don t Know IS Killing You! Charge Capture: What You Don t Know IS Killing You! Kauser Karwa MBA, RHIA, CDIP Manager McGladrey Bob Medcalf CEO Net Revenue Associates May 14, 2015 Objectives 1. Gain a broad level understanding on

More information

Oklahoma Health Care Authority

Oklahoma Health Care Authority Oklahoma Health Care Authority Recovery Audit Contract Provider Outreach & Education Presentation October 22, 2013 1 Agenda Introductions HMS Overview Medicaid RAC Review Process Provider Outreach & Education

More information

GMI Carrier EDI 214 Business Documentation

GMI Carrier EDI 214 Business Documentation GMI Carrier EDI 214 Business Documentation Joel Stamp Updated 1 Executive Summary This documentation addresses both business and some technical information for General Mills EDI 214 freight order status

More information

Briefing Book Guidance for Company

Briefing Book Guidance for Company 1 Briefing Book Guidance for Company General Points for Preparing a Briefing Book: Use the provided template to submit a Briefing Book (BB) to NICE Scientific Advice (SA) in Microsoft Word format. The

More information

Assessment Report Sample Candidate

Assessment Report Sample Candidate Assessment Report Sample Candidate Diagrammatic Analysis Aptitude-Rx Generated on: 3-Jan-2017 Page 2 2017 Willis Towers Watson. All rights reserved. Contents Introduction to Assessment Report... 3 Total

More information

QC and Changing Lots

QC and Changing Lots QC and Changing Lots Back to the Basics Karen Hoffman MT(ASCP) Senior Technical Integration Specialist Laboratory Solutions Services Sysmex America, Inc. Objectives On completion of this training you should

More information

Office of Planning, Design and Construction. Capital Program Update May 10, 2017

Office of Planning, Design and Construction. Capital Program Update May 10, 2017 Office of Planning, Design and Construction Capital Program Update May 10, 2017 Projects Under Construction Translational Research Center Translational Research Center Phase I Site work Status: Completed

More information

Consulted With Post/Committee/Group Date Eileen Hatley Data Quality Manager 15 th March 2016

Consulted With Post/Committee/Group Date Eileen Hatley Data Quality Manager 15 th March 2016 Data Quality Strategy Corporate / Strategic Register No: 11072 Status: Public Developed in response to: Best practice, Trust Requirement Contributes to CQC Regulations 12, 13, 17 Consulted With Post/Committee/Group

More information

Head Fixation Using a Vac-Lok Cushion during Neuroendovascular Therapy

Head Fixation Using a Vac-Lok Cushion during Neuroendovascular Therapy Journal of Neuroendovascular Therapy 2016; 10: 116 120 Online June 10 2016 DOI: 10.5797/jnet.oa.2016-0021 Head Fixation Using a Vac-Lok Cushion during Neuroendovascular Therapy Daisuke Uesaka, 1 Akinori

More information

Adverse Event Reporting

Adverse Event Reporting Adverse Event Reporting AE Case Receipt When we receive a case, we induct it through a well-oiled process that reduces the number of subsequent queries, classifies events appropriately, and increases the

More information

MARKEY CANCER CENTER CLINICAL RESEARCH ORGANIZATION STANDARD OPERATING PROCEDURES SOP No.: MCCCRO-P

MARKEY CANCER CENTER CLINICAL RESEARCH ORGANIZATION STANDARD OPERATING PROCEDURES SOP No.: MCCCRO-P Page 1 of 5 MARKEY CANCER CENTER CLINICAL RESEARCH ORGANIZATION STANDARD OPERATING PROCEDURES SOP No.: Title: Protocol Review and Monitoring Committee Revision: N/A Revision Date: N/A Functional and Administrative

More information

Annual report 2011 Clinical trials of medicines in humans

Annual report 2011 Clinical trials of medicines in humans Annual report 2011 Clinical trials of medicines in humans 1 Highlights Below is a summary of some of the topics covered by the Danish Health and Medicines Authority's annual report on clinical trials of

More information

3M 360 Encompass System Financial and data quality assurance

3M 360 Encompass System Financial and data quality assurance 3M 360 Encompass System Financial and data quality assurance 01 3M Medicode Classification Encoder 02 3M Medical History Assurance (MHA) 03 3M Data Quality Analytics (DQA) 04 3M HRG Assistant (HRGa) 05

More information

Introduction PART. 1 Why Technicians Need to Study Pharmacology and Therapeutics. 2 Pharmacokinetics

Introduction PART. 1 Why Technicians Need to Study Pharmacology and Therapeutics. 2 Pharmacokinetics PART Introduction 1 1 Why Technicians Need to Study Pharmacology and Therapeutics 2 Pharmacokinetics Understanding Pharmacology for Pharmacy Technicians 1 CHAPTER 1 Why Technicians Need to Study Pharmacology

More information

Department of Health & Human Services (DHHS) Pub Medicare Claims Processing Centers for Medicare &

Department of Health & Human Services (DHHS) Pub Medicare Claims Processing Centers for Medicare & CMS Manual System Department of Health & Human Services (DHHS) Pub. 100-04 Medicare Claims Processing Centers for Medicare & Medicaid Services (CMS) Transmittal 557 Date: MAY 6, 2005 CHAGE REQUEST 3848

More information

OHIP Billing Information for Telemedicine Services 1 September 2011

OHIP Billing Information for Telemedicine Services 1 September 2011 1 TABLE OF CONTENTS 1. Overview...2 2. Registration...2 3. Billing Information and Requirements...2 4. Excluded Telemedicine Services Fee Codes...4 5. Billing Requirements Summary...5 6. Manual Review...5

More information

Request for Proposals (RFP) Information Technology Independent Verification and Validation RFP No IVV-B ADDENDUM NO.

Request for Proposals (RFP) Information Technology Independent Verification and Validation RFP No IVV-B ADDENDUM NO. Request for Proposals (RFP) Information Technology Independent Verification and Validation ADDENDUM NO. 2 Questions and Answers RFP Amendments September 2015 Contained herein are the responses to the questions

More information

Clinical Data Acquisition Standards Harmonization (CDASH)

Clinical Data Acquisition Standards Harmonization (CDASH) Clinical Data Acquisition Standards Harmonization () Prepared by: CDISC Team Section Table of Contents Page 1.0 Orientation... 1 1.1 Purpose... 1 1.2 Organization of this Document... 1 1.2.1 General Notes...2

More information

Auditing Standard for Islamic Financial Institutions No. 6

Auditing Standard for Islamic Financial Institutions No. 6 Auditing Standard for Islamic Financial Institutions No. 6 External Shari ah Audit (Independent Assurance Engagement on an Islamic Financial Institution s Compliance with Shari ah Principles and Rules)

More information

Health Data Management

Health Data Management Western Technical College 10530176 Health Data Management Course Outcome Summary Course Information Description Career Cluster Instructional Level Total Credits 2.00 Total Hours 54.00 Introduces the use

More information